ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

In Brief: Kennedy, Waxman May Agree On Simple Extension Of Biomedical Research Authority, Including NCI

November 21, 1980